|
Oct 4
|
Clarivate in partnership with Abiquifi Announces Annual Summit LATAM Agenda
|
|
Sep 25
|
Clarivate Unveils Comprehensive Framework to Evaluate the Societal Impact of Research
|
|
Sep 24
|
New Clarivate Report Reveals Challenges and Trends Shaping IP Operations
|
|
Sep 23
|
Loss-Making Clarivate Plc (NYSE:CLVT) Expected To Breakeven In The Medium-Term
|
|
Sep 23
|
Clarivate and Relatable Healthcare Forge Strategic Partnership to Transform Medtech Sales Contracting Process
|
|
Jul 30
|
Clarivate Introduces New OFF-X ™ Platform for Preclinical and Clinical Safety Intelligence
|
|
Jul 24
|
Clarivate Director Richard Roedel to Retire from Board of Directors
|
|
Jul 17
|
Clarivate Plc's (NYSE:CLVT) Intrinsic Value Is Potentially 96% Above Its Share Price
|
|
Jul 16
|
Clarivate to Report Second Quarter 2024 Results on August 6, 2024
|
|
Jul 16
|
Clarivate Annual G20 Scorecard Examines Global Research and Innovation Trends Across G20 Members
|
|
Jun 24
|
Clarivate Launches IP Collaboration Hub
|
|
Jun 20
|
Clarivate Reveals World's Leading and Trusted Journals with the 2024 Journal Citation Reports
|
|
Jun 19
|
Clarivate Identifies Seven Innovators in Antibody Drug Conjugates in New Companies to Watch Report
|
|
May 22
|
Clarivate Identifies Five Breakthrough Medical Technologies Set to Transform Patient Care in 2024
|
|
May 9
|
OMRON Selects IPfolio from Clarivate
|
|
May 8
|
Shareholders in Clarivate (NYSE:CLVT) are in the red if they invested three years ago
|
|
May 8
|
Clarivate Reports First Quarter 2024 Results
|
|
May 7
|
Clarivate Introduces Epidemiology Intelligence™ for Precision Patient Population Analysis
|
|
May 2
|
Clarivate Enhances Cortellis CMC Intelligence with Post-Approval Module to Accelerate Regulatory Success
|
|
May 1
|
Clarivate Declares Dividend on Mandatory Convertible Preferred Shares
|